These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38067192)

  • 1. Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function.
    Judina A; Niglas M; Leonov V; Kirkby NS; Diakonov I; Wright PT; Zhao L; Mitchell JA; Gorelik J
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.
    Adão R; Mendes-Ferreira P; Maia-Rocha C; Santos-Ribeiro D; Rodrigues PG; Vidal-Meireles A; Monteiro-Pinto C; Pimentel LD; Falcão-Pires I; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):255-265. PubMed ID: 30339273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes.
    Fontana M; Olschewski H; Olschewski A; Schlüter KD
    Br J Pharmacol; 2007 Jul; 151(6):779-86. PubMed ID: 17533419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.
    Vanderpool RR; Gorelova A; Ma Y; Alhamaydeh M; Baust J; Shiva S; Tofovic SP; Hu J; Nouraie SM; Gladwin MT; Sharifi-Sanjani M; Al Ghouleh I
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca
    Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F
    J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
    Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
    Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
    Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right-ventricular dysfunction in HFpEF is linked to altered cardiomyocyte Ca
    Hegemann N; Primessnig U; Bode D; Wakula P; Beindorff N; Klopfleisch R; Michalick L; Grune J; Hohendanner F; Messroghli D; Pieske B; Kuebler WM; Heinzel FR
    ESC Heart Fail; 2021 Aug; 8(4):3130-3144. PubMed ID: 34002482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
    Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Jani V; Aslam MI; Fenwick AJ; Ma W; Gong H; Milburn G; Nissen D; Cubero Salazar IM; Hanselman O; Mukherjee M; Halushka MK; Margulies KB; Campbell KS; Irving TC; Kass DA; Hsu S
    Circulation; 2023 Jun; 147(25):1919-1932. PubMed ID: 37194598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
    Prisco SZ; Eklund M; Moutsoglou DM; Prisco AR; Khoruts A; Weir EK; Thenappan T; Prins KW
    J Am Heart Assoc; 2021 Nov; 10(22):e022722. PubMed ID: 34747187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension reduces energy efficiency of right, but not left, rat ventricular trabeculae.
    Pham T; Nisbet L; Taberner A; Loiselle D; Han JC
    J Physiol; 2018 Apr; 596(7):1153-1166. PubMed ID: 29363144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart.
    Handoko ML; Lamberts RR; Redout EM; de Man FS; Boer C; Simonides WS; Paulus WJ; Westerhof N; Allaart CP; Vonk-Noordegraaf A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1752-9. PubMed ID: 19734361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic Effects of Prostacyclins on the Right Ventricle Are Abolished in Isolated Rat Hearts With Right-Ventricular Hypertrophy and Failure.
    Holmboe S; Andersen A; Johnsen J; Nielsen JM; Nørregaard R; Bøtker HE; Clapp LH; Nielsen-Kudsk JE
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):1-12. PubMed ID: 27652910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension.
    Tanaka S; Yamamoto T; Mikawa M; Nawata J; Fujii S; Nakamura Y; Kato T; Fukuda M; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Kobayashi S; Yano M
    Heart Rhythm; 2022 Jun; 19(6):986-997. PubMed ID: 35134547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
    Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
    Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.